Jam

Achieve Life Sciences priced a public offering of common stock and warrants at $3.00 per share to fund its cytisinicline program, targeting nicotine dependence. The offering, expected to close around June 30, 2025, aims to raise approximately $45 million, which will be used to advance cytisinicline through the FDA approval process. Cytisinicline, with Breakthrough Therapy designation, is designed to interact with nicotine receptors, potentially aiding smoking cessation.

Ecopetrol S.A. is contesting a COP 1.0 trillion tax assessment related to gasoline imports in Colombia, with an additional COP 2.1 trillion in estimated interest. The Tax Authority demands corrections to customs declarations between 2022-2024. The refinery is challenging the assessment and has been paying VAT on gasoline/diesel imports since January 2025, while maintaining its right to challenge the interpretation. The company, a major energy player, also highlights its international presence and commitment to compliance.

Sage Potash Corp. closed a non-brokered private placement, raising C$6 million, exceeding its initial C$4 million target. The financing will accelerate field activity, planning, and permitting for its Utah potash project. The offering involved 24 million units and warrants. Proceeds will also fund exploration, infrastructure planning, and working capital. Securities are subject to a hold period, and the TSX Venture Exchange granted conditional approval.

Zentek Ltd. is adapting its ZenGUARD™ Enhanced Air Filter commercialization strategy in Canada. Following a Health Canada request for information, the company withdrew its PMRA submission and intends to market the filters as a Class I medical device. Zentek, focused on patented technology for enhanced product performance, aims to improve HVAC filters and is developing aptamer-based technology with McMaster University.

Independent Bank Corporation will release its Q2 2025 earnings on July 24, 2025, around 8:00 a.m. ET, accessible on its website. A conference call will follow at 11:00 a.m. ET with Brad Kessel, Gavin Mohr, and Joel Rahn. Replay details are provided. Independent Bank, with ~$5.3B in assets, offers various financial services across Michigan’s Lower Peninsula.

Merck’s ENFLONSIA (clesrovimab-cfor), a new monoclonal antibody for RSV prevention in infants under eight months, has received a positive recommendation from the CDC’s ACIP. Approved by the FDA, ENFLONSIA aims to protect against RSV lower respiratory tract disease, with ordering for the 2025-2026 season starting in July. The standardized dose provides rapid, lasting protection for a typical five-month RSV season, with potential accessibility via the Vaccines for Children Program.

Verint Engage 2025, the annual CX Automation conference, will feature Olympic swimming champion Katie Ledecky as a keynote speaker. Ledecky will inspire attendees with her message, “Make the Impossible Possible,” and share insights on achieving peak performance, drawing parallels between her journey and business challenges. The conference, held in Orlando, Florida in September 2025, will focus on AI-driven CX and how leading brands are achieving stronger outcomes.

El Pollo Loco launches new quesadillas just in time for summer, featuring their fire-grilled chicken and free guacamole. Available in Creamy Chipotle and Salsa Verde flavors, they’re designed for easy on-the-go enjoyment. Customers can purchase a la carte or in a combo. Partnering with NBA star Dalton Knecht, El Pollo Loco also offers a “Dalton Dunk Quesadilla Challenge” for rewards members.

Barksdale Resources plans an ambitious fall drill program at its Sunnyside project, aiming for a 67.5% ownership stake following promising spring drill results. The company’s focus is on copper mineralization, with potential to explore near-surface and deeper porphyry targets. Preliminary results confirmed copper, with the fall campaign seeking to quantify resources and satisfy earn-in requirements. Barksdale also recently moved to the OTCQB market.

Julong Holding Limited (JLHL) priced its IPO at $4.00 per share, raising approximately $5.0 million through the offering of 1,250,000 Class A ordinary shares. JLHL, trading on Nasdaq as “JLHL” from June 26, 2025, provides intelligent integrated solutions for various properties in China. US Tiger Securities, Inc. acted as the sole book-runner. The offering is expected to close on June 27, 2025.